Source: PharmiWeb

Ropack: FOR SALE: State-of-the-Art cGMP-Qualified Solid Dosage Development and Manufacturing Facility

FOR SALE: State-of-the-Art cGMP-Qualified Solid Dosage Development and Manufacturing FacilityThe 100,000+ sq.Ropack Pharma Solutions

Read full article »
Ropack's Competitors | Ropack's News | Ropack's Financials
Stay up-to-date with the latest news on Ropack, Inc.
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Yves Massicotte's photo - President & CEO of Ropack, Inc.

President & CEO

Yves Massicotte

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on Ropack, Inc.